Cell and Gene Therapies also known as (ETMPs) have continued to evolve in recent years. Over the last 15 years the industry and regulatory bodies have continued to learn more about them and in recent year there have been more and more guidance documents released outlining what the regulating bodies want the manufacturers and developers of these different biologic products to look for and adhere to during development.
Cell and Gene Therapies are Personalized medicine meaning, one patient, one drug. These types of drugs are not produced in large scale or in batches like the standard biologics or drugs we have been used to manufacturing up to this point. They are made in very small batches that are produced in laboratory setting but require the same environmental controls as your typical aseptic processing but a much smaller scale.
Listen to the full episode “Pharmaceutical Industry Outlook” now!
Issues with Approval
The issues companies face when manufacturing cell and gene is that they are introducing variability right away in the process in terms of the active ingredient. In this type of manufacturing, the active ingredient is the specific patient’s genome. With the variable ingredient, manufacturers do not know what they are working with upfront which makes the process difficult. It is a non-tradition way of thinking that makes validating a process that has that kind of variability hard on cell and gene companies without experience in this area.
The Non-traditional Approach
This approach to drug approval is based on an individualized patient’s genetic makeup and requires the developers to make a constant process of taking the patient’s genetic material and producing the cell and gene therapy dose at the end. Developers have to be able to categorize the variable, walk it through the process, and then categorize it again at the end making sure it is safe and effective for the patient even though it is based on their cell and gene genetic material.
About RCA’s Biotech Consulting Services
Regulatory Compliance Associates® can assist you in ensuring the quality of your biologics or biosimilar product during its entire lifecycle. From pre-market to post-market reviews, inspection, and compliance, our Biotech consulting experts can shepherd your biologics through design, labeling, promotion, production, and testing. Our Biologics consultants & consulting services include:
Regulatory Affairs
Regulatory affairs is Regulatory Compliance Associates® backbone and we fully understand the complexities of the biologics industry. Our biotech consulting expertise spans all facets and levels of Regulatory Affairs, from early phase & bioanalytical sciences through late phase and post approval.
- Preclinical & CMC Consulting
- FDA Meetings & Briefing Package Assistance
- Clinical Trial Applications
- Marketing Applications
- Medical Writing
- Lifecycle Management
- Regulatory Submission & Strategic Support
- eCTD Publishing
- Strategic Consulting & Intelligence
- US Agent
- Project Management Support
- Clinical Development Support
- Clinical Research Organization (CRO) Sourcing
- Analytical Development Support
- Bioassay Design & Validation
- Immunoassay Support
- Statistical Analysis & Specification Setting
Compliance Assurance
Increasingly, life science companies are feeling the pressure of greater scrutiny by regulators, and responding by developing sustainable compliance strategies. Whether it’s biologics consultants preparing for an audit, developing a response to an FDA finding, or remediation to an adverse event, Regulatory Compliance Associates® biotech consulting global team can help.
- Assessments
- Current Good Manufacturing Practice (cGMP)
- Corrective & Preventive Action (CAPA), Investigations & Deviations
- Facility & Maintenance
- Data Integrity
- Quality System Gap Assessment
- Audits
- Supplier Audits
- CRO Audits
- cGMP Compliance Audits: Manufacturing, Pilot Plant, Laboratory
- cGLP Audits
- Good Clinical Practices
- Preparation, Training & Inspection Readiness
- cGMP Fundamentals (Annual Training Required by Regulations)
- Quality System Regulation
- Risk Management
- Investigations, Deviations & CAPA & Root Cause Analysis
- Validation & Technology Transfer
- Purchasing Controls & Supplier Management
- Document Management & Change Control
- Audit Readiness
- Quality Culture & Management Responsibility
- Data Integrity & Good Documentation Practices (GDP) Centered on How the Data is Recorded, How to Correct an Error, and How to Document the Reason(s) for the Error
Quality Assurance
Regulatory Compliance Associates® Quality consulting services include assessments, strategy, implementations, staff augmentations, and identification of quality metrics. Our biologics consultants goal is to ensure continuous improvement, aligning with your business needs and goals. Our biotech consulting subject matter experts have experience spanning major corporations and start-ups.
We know firsthand how to achieve, maintain, and improve quality, and we excel in transferring this knowledge to your organization.
- Quality Management System Implementation
- SOP Development
- Document Control Systems
- Change Control
- Laboratory Operations & Control
Remediation Services
Regulatory Compliance Associates® is widely recognized within the life science industry and global regulatory agencies for its ability to help companies successfully resolve complex remediation services scenarios. With a proven track record of success, Regulatory Compliance Associates® biologics consultants have significant experience with the development of responses to 483 Observations, Warning Letters, Untitled Letters and Consent Decrees.
- Regulatory Action
- 483 Response & Remediation
- Warning Letter Response & Remediation
- Consent Decree Response & Remediation
- Oversight Services
- Consulting
- Comprehensive Audits
- Remediation Plan Development & Implementation
- Manufacturing Support
- Re-validation of Existing Equipment & Processes
- Remediation of System Deficiencies Related to, Manufacturing Process, Equipment, or Facility
- Facility Improvements (Aging Facilities)
Strategic Consulting
Whether it’s a corporate needs analysis, corporate growth / transformation strategy or due diligence / acquisition, Regulatory Compliance Associates® worldwide biotech consulting experience can help ensure a successful mix of top-notch advice and people so your engagement is on time, on budget, and you’re never embroiled in a costly mistake.
- Portfolio Management
- Mergers & Acquisitions / Due Diligence
- Staffing Support
Biostatistics
At Regulatory Compliance Associates, we recognize that biostatistics continues to change life science consulting one project at a time. Our biostatistics consultant Experts can help with both your internal or external clinical study and medical research needs.
RCA biostatisticians will create a custom scope of work based on the applicable statistical tests and predictive techniques that increase regulatory compliance. In fact, our statistical consulting team approach to clinical study design and clinical research provides Regulatory Compliance Associates clients a true competitive advantage during product development and commercialization.
Our biostatistics consulting services include:
- Clinical research
- Medical research
- Epidemiological research
- Disease occurrence research
- Disorder prevalence research
- Data safety monitoring
- Adverse event research
Regulatory Compliance Associates healthcare consulting Experts can provide quantitative analysis that propels your commercialization projects faster and more accurately. Our statistical consulting Experts can provide deep insights into the regulatory compliance process of what can help you with your regulatory submission.
Biostatistics is more than just getting your white paper published – it’s about saving lives and getting the right products to market. RCA’s epidemiological consulting team will provide a custom scope of work based on your clinical research studies. For over 20 years we’ve partnered with clinicians, PhD’s, MD’s, and epidemiologists to increase the success of their initiatives, including clients from:
- Hospitals and health care systems
- Government agencies and departments
- Academic and university research programs
- Life science manufacturers and organizations
- Private equity and venture capital
Regulatory Compliance Associates biostatistics consulting team provides a diverse set of healthcare consulting services during the clinical research trials process, including:
- Biostatistics
- Clinical trials
- Phase 1 clinical trial
- Phase 2 clinical trial
- Phase 3 clinical trial
- Phase 4 clinical trial
- Medical trials
- Clinical trial oversight
- World wide clinical trials
- Decentralized clinical trial
- Randomized clinical trial
- Clinical test oversight
- Pragmatic trial
- Open label studies
- Clinical trial oversight
- Clinical trials
About Regulatory Compliance Associates
Regulatory Compliance Associates (RCA) provides biologics consulting & biotech consulting to the following industries for resolution of life science challenges:
We understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA, Health Canada, MHRA and globally-regulated companies.
As your partners, we can negotiate the potential minefield of regulatory compliance and regulatory due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.
- Founded in 2000
- Headquartered in Wisconsin (USA)
- Expertise backed by over 500 industry subject matter experts
- Acquired by Sotera Health in 2021
About Sotera Health
The name Sotera Health was inspired by Soteria, the Greek goddess of safety, and reflects the Company’s unwavering commitment to its mission, Safeguarding Global Health®.
Sotera Health Company, along with its three best-in-class businesses – Sterigenics®, Nordion® and Nelson Labs®, is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. With a combined tenure across our businesses of nearly 200 years and our industry-recognized scientific and technological expertise, we help to ensure the safety of over 190 million patients and healthcare practitioners around the world every year.
We are a trusted partner to more than 5,800 customers in over 50 countries, including 40 of the top 50 medical device companies and 8 of the top 10 pharmaceutical companies.
To begin the Regulatory Compliance Associates scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.